Patent · US Active

Imidazolidinone derivatives

US7625902B2 · kind B2 · utility

1Cited by

0References

24Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Henrietta Dehmlow · Weil am Rhein, DE
Bernd Kuhn · Sursee, CH
Ulrike Obst Sander · Sursee, CH
Stephan Roever · Inzlingen, DE
Tanja Schulz-Gasch · Ziefen, CH
Matthew Wright · Basel, CH

Key dates

Filing date	Mar 24, 2008
Grant date	Dec 1, 2009
Priority date	—
Expiry date	Mar 24, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention is concerned with novel imidazolidinone derivatives of formula (I):wherein R1 to R11 and X are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds bind to LXR alpha and LXR beta and can be used in pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.